| [1] |
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990—2015: A systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053): 1659-1724.
|
| [2] |
Tonetti MS, Jepsen S, Jin LJ, et al. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action[J]. J Clinic Periodontology, 2017, 44(5): 456-462.
|
| [3] |
Sun MM, Ji YT, Li Z, et al. Ginsenoside Rb3 inhibits pro-inflammatory cytokines via MAPK/AKT/NF-κB pathways and attenuates rat alveolar bone resorption in response to Porphyromonas gingivalis LPS[J]. Molecules, 2020, 25(20): 4815.
|
| [4] |
Kong P, Cui ZY, Huang XF, et al. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention[J]. Signal Transduct Target Ther, 2022, 7(1): 131.
|
| [5] |
Zhang JQ, Xie MR, Huang XF, et al. The effects of Porphyromonas gingivalis on atherosclerosis-related cells[J]. Front Immunol, 2021, 12: 766560.
|
| [6] |
Tall AR, Bornfeldt KE. Inflammasomes and atherosclerosis: A mixed picture[J]. Circ Res, 2023, 132(11): 1505-1520.
|
| [7] |
Paerewijck O, Lamkanfi M. The human inflammasomes[J]. Mol Aspects Med, 2022, 88: 101100.
|
| [8] |
Lin J, Huang DM, Xu HW, et al. Macrophages: A communication network linking Porphyromonas gingivalis infection and associated systemic diseases[J]. Front Immunol, 2022, 13: 952040.
|
| [9] |
Aral K, Berdeli E, Cooper PR, et al. Differential expression of inflammasome regulatory transcripts in periodontal disease[J]. J Periodontol, 2020, 91(5): 606-616.
|
| [10] |
Zhang J, Liu XQ, Wan CY, et al. NLRP3 inflammasome mediates M1 macrophage polarization and IL-1β production in inflammatory root resorption[J]. J Clin Periodontol, 2020, 47(4): 451-460.
|
| [11] |
Li WL, Hua LG, Qu P, et al. NLRP3 inflammasome: A novel link between lipoproteins and atherosclerosis[J]. Arch Med Sci, 2016, 12(5): 950-958.
|
| [12] |
Liaqat A, Asad M, Shoukat F, et al. A spotlight on the underlying activation mechanisms of the NLRP3 inflammasome and its role in atherosclerosis: A review[J]. Inflammation, 2020, 43(6): 2011-2020.
|
| [13] |
van der Heijden T, Kritikou E, Venema W, et al. NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report[J]. Arterioscler Thromb Vasc Biol, 2017, 37(8): 1457-1461.
|
| [14] |
Zheng F, Xing SS, Gong ZS, et al. Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice[J]. Mediat Inflamm, 2014, 2014: 507208.
|
| [15] |
Orecchioni M, Kobiyama K, Winkels H, et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production[J]. Science, 2022, 375(6577): 214-221.
|
| [16] |
Wang LF, Sun L, Byrd KM, et al. AIM2 inflammasome's first decade of discovery: Focus on oral diseases[J]. Front Immunol, 2020, 11: 1487.
|
| [17] |
Xue F, Shu R, Xie YF. The expression of NLRP3, NLRP1 and AIM2 in the gingival tissue of periodontitis patients: RT-PCR study and immunohistochemistry[J]. Arch Oral Biol, 2015, 60(6): 948-958.
|
| [18] |
Arunachalam LT, Suresh S, Lavu V, et al. Association of salivary levels of DNA sensing inflammasomes AIM2, IFI16, and cytokine IL18 with periodontitis and diabetes[J]. J Periodontol, 2024, 95(2): 114-124.
|
| [19] |
Li WJ, Zheng QW, Meng HX, et al. Integration of genome-wide association study and expression quantitative trait loci data identifies AIM2 as a risk gene of periodontitis[J]. J Clinic Periodontol, 2020, 47(5): 583-593.
|
| [20] |
Paulin N, Viola JR, Maas SL, et al. Double-strand DNA sensing Aim2 inflammasome regulates atherosclerotic plaque vulnerability[J]. Circulation, 2018, 138(3): 321-323.
|
| [21] |
Hsu CC, Fidler TP, Kanter JE, et al. Hematopoietic NLRP3 and AIM2 inflammasomes promote diabetes-accelerated atherosclerosis, but increased necrosis is independent of pyroptosis[J]. Diabetes, 2023, 72(7): 999-1011.
|
| [22] |
Fidler TP, Xue CY, Yalcinkaya M, et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis[J]. Nature, 2021, 592(7853): 296-301.
|
| [23] |
Du LP, Wang XY, Chen SY, et al. The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease[J]. Pharmacol Res, 2022, 186: 106533.
|
| [24] |
Yamaguchi Y, Kurita-Ochiai T, Kobayashi R, et al. Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis[J]. Pathog Dis, 2015, 73(4): ftv011.
|
| [25] |
Køllgaard T, Enevold C, Bendtzen K, et al. Cholesterol crystals enhance TLR2- and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis[J]. PLoS One, 2017, 12(2): e0172773.
|
| [26] |
Higuchi K, Ziauddin SM, Yamashita Y, et al. Initial periodontal treatment affects nucleotide-binding domain leucine-rich repeat-containing protein 3 inflammasome priming in peripheral blood mononuclear cells[J]. Arch Oral Biol, 2020, 110: 104625.
|
| [27] |
Ali Daily Z, Al-Ghurabi BH, Al-Qarakhli AMA, et al. Association between AIM2 and pycard genes polymorphisms and susceptibility to periodontitis with coronary heart disease[J]. Clin Cosmet Investig Dent, 2023, 15: 307-320.
|
| [28] |
Zeng XT, Leng WD, Lam YY, et al. Periodontal disease and carotid atherosclerosis: A meta-analysis of 17, 330 participants[J]. Int J Cardiol, 2016, 203: 1044-1051.
|
| [29] |
Orlandi M, Masi S, Lucenteforte E, et al. Periodontitis treatment and progression of carotid intima-media thickness: A randomized trial[J]. Eur Heart J, 2025: ehaf555.
|